Cardiovascular diseases remain the leading cause of mortality worldwide, with particularly high burdens observed in countries undergoing socioeconomic transition. A growing body of evidence highlights the central role of oxidative stress in the pathogenesis of atherosclerosis, thrombosis, and related cardiovascular disorders. Selenium, an essential trace element, has attracted sustained scientific attention due to its incorporation into selenoproteins with critical antioxidant and anti-inflammatory functions. This article presents a comprehensive, integrative analysis of selenium status and its relationship with cardiovascular disease, grounded strictly in the existing scientific literature. Epidemiological patterns of cardiovascular morbidity and mortality in Eastern Europe and Central Asia, including Uzbekistan and Russia, are examined alongside ecological and nutritional determinants of selenium availability. Mechanistic pathways linking selenium-dependent antioxidant systems, particularly glutathione peroxidase, to vascular homeostasis and platelet function are discussed in depth. Methodological approaches for selenium assessment and cardiovascular epidemiology are critically analyzed, emphasizing strengths and limitations inherent in population-based research. The results synthesized from prior studies suggest that suboptimal selenium status may exacerbate oxidative stress, endothelial dysfunction, and inflammatory responses, thereby contributing to increased cardiovascular risk. However, inconsistencies across studies underscore the complexity of selenium biology, including dose-response relationships, regional variability, and interactions with lifestyle factors such as smoking. The discussion addresses theoretical implications, unresolved controversies, and directions for future research, particularly the need for context-specific nutritional strategies and carefully designed intervention studies. This article aims to provide a rigorous conceptual framework for understanding selenium’s role in cardiovascular health and to inform both scientific inquiry and public health policy.

Selenium, cardiovascular disease, oxidative stress

Ageev F.T. et al. Epidemiology of cardiovascular diseases in Russia. Kardiovask Ter Prev. 2009;8(6):6–12.

Alissa E.M. et al. Selenium and cardiovascular disease. Med Sci Monit. 2003;9(1):RA9–18.

Combs G.F. Jr. Selenium in global food systems. Br J Nutr. 2001;85(5):517–547.

Fagerstrom K. et al. Smoking and selenium. J Nutr. 2002;132(6):1422–1423.

Forceville X. et al. Selenium in critically ill patients. Crit Care Med. 1998;26(9):1536–1544.

Freedman J.E. Oxidative stress and platelets. Arterioscler Thromb Vasc Biol. 2008;28(3):S11–S16.

Golubkina N.A. Fluorimetric method for selenium determination. Moscow: VNIIP; 1995.

Golubkina N.A. Selenium in medicine and ecology. Moscow: KMK; 2006.

Kharchenko V.I. et al. Mortality from cardiovascular diseases in Russia. Moscow: Meditsina; 2005.

Kurbanov R.D. et al. Cardiovascular epidemiology in Uzbekistan. Uzbek J Cardiol. 2023.

Lankin V.Z. et al. Oxidative stress and atherosclerosis. Vestn Ross Akad Med Nauk. 2004;(7):22–27.

Lubos E. et al. Glutathione peroxidase-1 in health and disease. Free Radic Biol Med. 2008;44(4):508–517.

Madamanchi N.R. et al. Reactive oxygen species in cardiovascular disease. Free Radic Biol Med. 2005;39(5):571–586.

Neve J. Selenium status and requirement. Nutr Rev. 2000;58(2 Pt 1):363–369.

Rebrova O.Yu. Statistical analysis in medicine. Moscow: Media Sfera; 2002.

Salonen J.T., Huttunen J.K. Selenium and cardiovascular diseases. Ann Clin Res. 1986;18(1):30–35.

Thomson C.D. Assessment of requirements for selenium and adequacy of selenium status. Eur J Clin Nutr. 2004;58(3):391–402.

Valko M. et al. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol. 2007;39(1):44–84.

Vladimirov Yu.A. Free radicals in biological systems. Moscow: Nauka; 1991.